ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) notified onThursday a Rs3,564 cut in the price of Remdesivir, a drug found to beeffective in treating patients hospitalised with coronavirus.

According to the notification, the new price of 100mg vial of the antiviralis fixed at Rs5,680.

The drug regulator has asked firms importing Remesivir to mention the drugprice on its packet.

On November 27, the federal cabinet had green-lighted a cut in the pricelink of the antiviral.